Li-Min Mu

1.0k citations
25 papers · 885 · h-index 17

Impact in

    • Nanoparticle-Based Drug Delivery
    • RNA Interference and Gene Delivery
    • Advanced biosensing and bioanalysis techniques

Papers in

    • RNA Interference and Gene Delivery 13
    • Advanced biosensing and bioanalysis techniques 4
    • Angiogenesis and VEGF in Cancer 3
    • Nanoparticle-Based Drug Delivery 12

Li-Min Mu

25 papers receiving 875 citations

Peers

Li-Min Mu
Comparison fields: 5 of 81
  • Biomaterials 358
  • Molecular Biology 479
  • Biomedical Engineering 278
  • Cancer Research 83
  • Oncology 149
Replace Cheng-Xiang Zhang with:
Cheng-Xiang Zhang China
Sara Amel Farzad Iran
Arthur Rekechenetskiy United States
Dan Huang China
Matin Chehelgerdi Iran
Donghang Xu China
Muhammad Ismail China
Florence Gattacceca France
Dae Hwan Shin South Korea
Li-Min Mu relative to Cheng-Xiang Zhang China Cheng-Xiang Zhang's profile →
Citations per field
00.5×2.7×
Cheng-Xiang Zhang · 1×
Citations per year

Countries citing papers authored by Li-Min Mu

Since Specialization
Citations

This map shows the geographic impact of Li-Min Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li-Min Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li-Min Mu more than expected).

Fields of papers citing papers by Li-Min Mu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li-Min Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li-Min Mu. The network helps show where Li-Min Mu may publish in the future.

Co-authors

The 25 scholars most cited alongside Li-Min Mu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Li-Min Mu Line = papers co-authored together Li-Min Mu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2014149
2 2017114
3 2013113
4 202168
5 201840
6 201540
7 201639
8 201737
9 201537
10 201734
11 201532
12 201725
13 201825
14 201823
15 201419
16 202016
17 202116
18 201914
19 201613
20 201311

About Li-Min Mu

Li-Min Mu is a scholar working on Molecular Biology, Biomaterials, Biomedical Engineering, Oncology and Immunology, having authored 25 papers that have together received 885 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (13 papers), Nanoparticle-Based Drug Delivery (12 papers), Nanoplatforms for cancer theranostics (8 papers), Drug Transport and Resistance Mechanisms (4 papers), Advanced biosensing and bioanalysis techniques (4 papers), Angiogenesis and VEGF in Cancer (3 papers), Cancer Cells and Metastasis (2 papers) and Nanopore and Nanochannel Transport Studies (2 papers). The work is most often cited by research in Biomaterials (358 citations), Molecular Biology (479 citations), Biomedical Engineering (278 citations), Cancer Research (83 citations) and Oncology (149 citations). Li-Min Mu has collaborated with scholars based in China, Thailand and United States. Frequent co-authors include Wan-Liang Lü, Rui-Jun Ju, Yao Zhao, Ji‐Feng Shi, Mengge Sun, Xiuying Li, Weiyu Zhao, Jingying Zhang, Cheng-Xiang Zhang and Xuetao Li. Their work appears in journals such as International Journal of Nanomedicine, Oncotarget, Journal of Biomedical Nanotechnology, Biomaterials and Nanomaterials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact